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Given the condition of the web of life on this planet after 10,000 years 
of agriculture and the consequent exponential growth of human pop-
ulation and human consumption patterns, do we need biotechnology 
and sustainable agriculture? The earth very much needs sustainable 
agriculture in the pragmatic sense, but whether or not sustainable agri-
culture needs biotechnology is an issue. There is a great enthusiasm 
about biotechnology, and the enthusiasts are promising much good. 
Well, I like enthusiasm as much as the next person, but let us see where 
it is coming from. For one thing this enthusiasm flows from the deep 
and ancient wheels of our civilization, a civilization that began when 
the Mesopotamians expanded their economy and their society by ten-
ding sheep and tilling barley a hundred centuries ago.
Almost ever since, we have placed the highest value on bringing na-
ture under human control. It is almost a religion or pathological obses-
sion. We should be aware of the past and control our enthusiasm for 
every powerful new tool that we come up with for controlling nature.
1 see parallels in biotechnology.
Biotechnology requires sophisticated tools and expertise which 
makes it expensive, limits its use, ownership, and control. This is the 
first and greatest social and ethical issues of all. With respect to disease 
control in animals, who will have this tool of biotechnology? More im-
portantly, who will control it? Will it be all of us, the potential victims 
of some accident, some mistake or some misdirection? Or will it be
controlled by private interests for the private gain of those who be-
cause of the competition in the industry keep the technology as their 
patentable property and their goals and activities away from public 
view, (probably secret)?
These are serious political questions. It would be nice to assume 
that democracy and justice will prevail, but it would be stupid to 
make that assumption. When one considers the power of these tech-
nologies and the enthusiasm for them, and the quarters from which 
the enthusiasm is coming and the blindness that usually accompanies 
it, we might as well face the fact that we could already be on the 
wrong track with biotechnology.
What is the impact of biotechnology on the environment, on consu-
mers, farming, and the animals on the farms? Biotechnology is being 
developed and applied for use in the areas of: diagnostic tests; products 
that will enable farmers to diagnose animal diseases quickly; immuni-
zation new vaccines against a wider range of afflictions and products 
for the regulation of animal immune systems and gene transfer and 
other genetic manipulations that are used to create strains of animals 
that have an enhanced immune response, disease resistance, and new 
antibiotics that work against a wider range of diseases.
DIAGNOSTIC TESTS
The new diagnostic tests could employ monoclonal antibody technol-
ogy to make a product that a lay person (e.g., farmer) could use to make 
a rapid, on the spot diagnosis of animal disease. Like litmus paper, the 
product could be dipped into the animal’s body fluid, and after proces-
sing, the farmer could determine what the disease was, or whether or 
not a disease agent was present. Whether or not such new diagnostic 
tests would create adverse social or ethical problems depends on how 
accurate they are, how they are used, and what sort of farms they give 
an advantage to.
On the positive side, diagnostic ability would give farmers a wider 
edge against diseases by allowing earlier and more specific treatment. 
With early detection, the effected animal or animals could be isolated 
sooner and could perhaps reduce the risk of infection to the rest of the 
herd. This would help the farmer follow a more sustainable agricultu-
ral strategy, by preventing disease rather than using powerful, danger-
ous drugs to eradicate disease after it has broken out. If the diagnostic 
tests are so employed, animals would benefit from a reduction in
Disease Control in Animals
diseases. Farmers would benefit in the reduction of veterinary costs 
and other overall herd health care costs. If the health of the herd is im-
proved by a shift away from disease-busting drugs to prevention, then 
consumers would benefit from a reduction in the incidence or likeli-
hood of toxins or drugs in the food chain.
If a products’ diagnostic effectiveness does not live up to its adver-
tiser’s promises, what happens? The farmer is getting somewhat less 
of a diagnostic tool than he or she is counting on, and this could be a 
serious problem. An inferior diagnostic test in the hands of a less than 
conscientious farmer, could be a formula for disease disaster. The farm-
er would be relying on an easy diagnosis, an easy solution, and an easy 
management system. In such a situation, a disease outbreak could ea-
sily get out of hand by the time the farmer gets around to calling the 
veterinarian.
If the farmer misreads the directions or misuses the diagnostic test, 
then the farmer might administer something to the animal that might 
only make matters worse. The diagnostic might promise too much in 
the way of simple solutions for complex disease problems, and where 
disease is concerned, mistakes are often irreversible.
If a diagnostic test is inexpensive, it will be accessible to the farmers 
involved in LISA, low input sustainable agriculture. If a diagnostic test 
is expensive, it will be used more by the capital-intensive, larger, fac-
tory-type operations, and thus give them an edge over the rest of the 
farming spectrum. In this case, the product would aid an operation 
that would have an adverse impact on the environment, on consumers, 
and on family farms. If the price makes the diagnostic test accessible to 
lower income or lower input farmers, it could give these farmers an 
edge over the corporate animal factory. Such diagnostic tests would 
seem to be most applicable to the operations with the smaller herds 
and the smaller flocks, rather than to large operations with tens of 
thousands of animals. It would be impractical for a large-scale opera-
tion to test each individual animal.
ANIMAL IMMUNIZATION
Improved immunization in animals would emphasize disease preven-
tion rather than disease control and would shift farmers away from 
using so many drugs. If the new vaccines and the new immune system 
regulators are cheap enough and easy to use, then they could aid sus-
tainable agriculture with a low-cost way to control disease and 
parasites.
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It is doubtful, however, that such powerful tools for disease control 
will be widely offered at low cost. The manufacturers of these prod-
ucts tend to recoup the years of research and development costs by set-
ting high profit margins once the products are on the market. Once 
these high profit margins are in place, the pharmaceutical industry 
does not usually allow the prices to drop. It is not always true that 
competition brings the prices down, sometimes they stay up. It is 
more likely that the manufacturers would be designing vaccines and 
immune system regulators for the animal production systems at the 
larger end of the production scale.
Large operators would be the most likely target of new products, 
because they have more to offer an investor. Large operations have 
virtually taken over egg and poultry production, and they have been 
taking on an increasingly larger share of the hog and dairy production 
in the past few decades. These operations have disease problems of 
their own, and from the point of view of the manufacturer, these farms 
are better, larger, more affluent, more stable, better informed, and a 
better return on the investment of research and development money.
It is difficult to imagine the agribusiness pharmaceutical industry in-
vesting a great deal of research and product development money in 
new vaccines and immune system regulators for the set of disease pro-
blems that are peculiar to low-input operations. Farmers using LISA 
are not big buyers, and the manufacturers are not likely to develop pro-
ducts that address their disease problems. It is likely, then, that the 
new vaccines and immune regulators will be designed primarily for the 
poultry, hog, and dairy industry where large numbers of animals are 
confined in a controlled environment. In this environment, disease 
problems are related to crowding, stress, and airborne disease agents. 
The constancy of these conditions, and the constancy of certain dis-
eases makes large operations the most likely candidates for profitable 
product development, such as new antibiotic products and the new 
strains of specific disease-resistant animals.
GENETIC ENGINEERING
The genetic engineering of animals for specific disease resistance 
would probably have the most clear-cut impacts on farm structure. 
Because of the high investment of capital and expertise that is required 
to carry out the genetic alteration of animals, only the well capitalized 
firms will be able to successfully conduct these research programs and 
develop these products. For various reasons, these firms would be
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likely to put high price tags on their products. The U.S. Supreme 
Court has recently supported the idea of patenting the products of this 
research, which would give a firm a monopoly over its creations. The 
firm would feel justified in recouping its research and development 
costs by charging a high price. Moreover, the purchasers of specific dis-
ease resistant animals would have to pay royalties or some kind of a 
premium for these special animals.
Additionally, the development of disease resistant animals may fur-
ther reduce genetic diversity. Instead of actually preventing diseases, 
the narrowing of the gene pool might open up the animal industries to 
disease vulnerability.
ANIMAL WELFARE
At first glance, the new vaccines, antibiotics, immune system regula-
tors, and disease resistant animals would seem to improve animal wel-
fare. If an animal is disease free, then animal welfare is high, but this 
may not always be the case. There is more to animal welfare than the 
simple absence of disease. There are social, emotional, and psychologi-
cal factors that generally do not concern producers unless they inter-
fere with production.
If the architects of biotechnology are attempting to nullify, circum-
vent or override these factors so that an animal can produce despite the 
environment or living conditions provided, then all-around animal 
welfare will sink to the lowest common denominator. This trend has 
already been seen in controlled environment-intensive operations 
where a combination of isolation, subtherapeutic doses of antibiotics, 
and the use of potent drugs have made mass production profitable. 
Without these intensive management tools, controlled environments 
would probably produce nothing but disease outbreaks and dead 
animals.
What would happen if these environment-intensive operations ob-
tain the tools from biotechnology? The confinement buildings could 
be filled with animals that are virtually disease proof, because of the 
new vaccines, the immune regulators, or disease resistant genes.
Would it not be possible to sustain maximally profitable production 
under even more severe isolation, physical restriction, and crowding? 
Animal living conditions and animal stress could become even worse 
than they are now, and yet production would increase.
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It is quite likely that animal welfare would worsen, because the 
new tools would increase overhead, which would have to be recovered 
through increased production. Production could be elevated, as it usu-
ally is, by increasing animal numbers, which could be accomplished 
without the previous restraint of disease induced by stress, crowding 
and other close-confinement conditions. If biotechnology is to take 
this direction and foster an increase in animal production, farm ani-
mals would not be the only ones to suffer the consequences. When ani-
mal production is dominated by mass production operations, there 
will be adverse impacts on consumers, the environment, and on the 
rest of the spectrum of farming.
IMPACT OF HIGH-INPUT INTENSIVE ANIMAL PRODUCTION SYSTEMS
The impacts of high-input intensive animal production systems on 
consumers, will cause a deterioration of the overall quality of the meat, 
milk, and eggs produced. The more extreme manipulations of genetics, 
growth cycles, and living conditions seems to produce animal products 
that are watery, flabby, bland, colorless, and artificial. This may be one 
of the factors behind the shift away from animal products in recent 
years.
There are increased human health risks that are attributable to the 
substitution of antibiotics and drugs for labor intensive animal care 
methods. Two hazards face the consumers of the factory animal pro-
duct. There is the greater likelihood that an animal product may con-
tain a residue of a toxic drug or chemical used in disease prevention. 
There is also an increased chance of contracting an animal-borne dis-
ease such as food poisoning from Salmonella which may have become 
resistant to one or more of the antibiotics routinely used in these large 
systems.
The huge confinement operations affect the environment by crea-
ting a constant odor problem; infestations of flies, mice, and other 
pests; as well as stream and groundwater pollution. Many of these 
operations are so specialized, that it is uneconomical or inconvenient 
to redistribute the animal wastes back onto the croplands. In some 
places, waste is dumped or contained in holding ponds or treated and 
added back into animal feeds. Thus, nitrogen and other valuable nut-
rients found in waste are not returned to the soil. This is certainly not 
a sustainable agricultural practice.
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Factory facilities tend to require feeds that will store easily and 
move through the pipelines, augers, and other moving parts of auto-
mated feeding systems. These large operations also require feeds that 
will put weight on animals rather quickly, so they can move a large 
number of animals per year through their expensive buildings. They 
will use mostly grain concentrates and other high-protein feedstuffs. 
To furnish these in sufficient volume, corn, soybeans, and other feed 
crop farmers have had to resort to chemical fertilizers, pesticides, 
herbicides, and many other environmentally invasive high-input 
methods.
If biotechnology is geared towards the biggest operations and they 
take over production, there will also be an impact on farm structure. 
The impact is best illustrated by what has happened in the poultry 
business. Many a farm family used to make a decent living by produc-
ing chickens and eggs for local markets. Today, these poultry farmers 
are virtually all gone because pharmaceutical, grain, feed, and other 
well-capitalized companies replaced them with antibiotics, automa-
tion, and quick- grow chickens. Eggs, chickens, and turkeys are very 
cheap now, but at what cost to the environment, the farmers, the farm 
communities, and to the chickens themselves? The broiler chicken 
cannot even walk anymore. Now that is a small consideration when 
you figure that it is going to be eaten in seven weeks, but it is just ano-
ther sign of the times. By quietly researching and developing biotech-
nological products before the impacts are known, those who have the 
greatest investments in the present modes of agricultural production 
could work to resist rather than to assist the increasing need for sus-
tainable agriculture.
Consumers do not want cheap, bland, “plastic” animal products 
that have been mass produced; they want color, taste, quality, and pu-
rity in their foods. Even the supermarkets, who scoffed at carrying or-
ganic food five years ago, are now trying to get organic food on their 
shelves. Consumer demand, together with increasing public concern 
for the environment, could soon make sustainable agriculture very 
profitable.
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